Literature DB >> 8817189

Pseudomonas aeruginosa clinical isolates: serotypes, resistance phenotypes and plasmid profiles.

M Millesimo1, G de Intinis, M G Chirillo, T Musso, D Savoia.   

Abstract

78 Pseudomonas aeruginosa strains were isolated from the respiratory tract of 56 patients, 15 of which were affected by cystic fibrosis (CF). The epidemiological typing scheme was based on serotyping, antibiotic resistance pattern and plasmid DNA profile. All strains (except 2 mucoid strains) were typed using a rapid slide O-agglutination technique. Most common serotypes in both group were 0:1, 0:10 and 0:6. Moreover we observed a correlation among 0:12 serotype and CF patients. Plasmid DNA analysis showed that 45.2% (on average) of strains isolated from patients with and w/o CF harboured 1-3 plasmids ranging in size from 1 to 15 Md. Plasmid prevalence was higher in strains isolated from CF patients in specimens collected after antibiotic therapy. A correlation was found between 1 and 1.9 Md plasmids and resistance to aminoglycosides. Our results indicate that the analysis of antibiotic resistance phenotypes combined with plasmid analysis may be useful, in association to serotyping, to characterize the circulation of P. aeruginosa strains and the spread of resistance in these bacteria.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8817189     DOI: 10.1007/bf00145496

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  23 in total

1.  Assisted evaluation of antibiotic resistance development in Pseudomonas aeruginosa from intensive care units.

Authors:  L Pagani; R Pizzala; P Garbagnoli
Journal:  Microbiologica       Date:  1992-10

2.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

3.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

4.  Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection.

Authors:  M Kielhofner; R L Atmar; R J Hamill; D M Musher
Journal:  Clin Infect Dis       Date:  1992-02       Impact factor: 9.079

5.  Resistance mechanisms of multiresistant serotype 012 Pseudomonas aeruginosa isolated in Europe.

Authors:  T L Pitt; D M Livermore; G Miller; A Vatopoulos; N J Legakis
Journal:  J Antimicrob Chemother       Date:  1990-09       Impact factor: 5.790

Review 6.  The impact of tracheal intubation on host defenses and risks for nosocomial pneumonia.

Authors:  S A Levine; M S Niederman
Journal:  Clin Chest Med       Date:  1991-09       Impact factor: 2.878

7.  Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Authors:  J W Mouton; J G den Hollander; A M Horrevorts
Journal:  J Antimicrob Chemother       Date:  1993-06       Impact factor: 5.790

8.  Protein patterns, serotyping and plasmid DNA profiles in the epidemiologic fingerprinting of Pseudomonas aeruginosa.

Authors:  S Walia; T Madhavan; T Williamson; A Kaiser; R Tewari
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

9.  Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens.

Authors:  G A Jacoby; M J Blaser; P Santanam; H Hächler; F H Kayser; R S Hare; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

10.  Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa.

Authors:  J W Ogle; J M Janda; D E Woods; M L Vasil
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 7.759

View more
  3 in total

1.  Use of subtractive hybridization to identify a diagnostic probe for a cystic fibrosis epidemic strain of Pseudomonas aeruginosa.

Authors:  Yasmin N Parsons; Stavroula Panagea; Catherine H M Smart; Martin J Walshaw; C Anthony Hart; Craig Winstanley
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

2.  lfnA from Pseudomonas aeruginosa O12 and wbuX from Escherichia coli O145 encode membrane-associated proteins and are required for expression of 2,6-dideoxy-2-acetamidino-L-galactose in lipopolysaccharide O antigen.

Authors:  Jerry D King; Erin F Mulrooney; Evgeny Vinogradov; Bernd Kneidinger; Kristen Mead; Joseph S Lam
Journal:  J Bacteriol       Date:  2007-12-21       Impact factor: 3.490

3.  Phenotypic and genotypic characterization of Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  I Leone; M G Chirillo; T Raso; M Zucca; D Savoia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-17       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.